CCL2 and thyroid gland papillary carcinoma: Moreover, the modulation of CCL2 by factors such as Canagliflozin, PFHxA, USP15, and Vitamin D further connects its involvement in TC development, particularly in association with papillary thyroid carcinoma and Hashimoto’s thyroiditis [36, 38, 39].